|
Interagency Workgroup on Technology to Facilitate Aging in Place
|
Research Initiative
|
ACL, CMS, FDA
|
NIA, NCI, NHLBI, NIBIB, NINDS, NINR
|
The purpose of this Trans-NIH/Inter-Agency group is to develop new platforms for everyday life technology that will enhance the common goals of multiple NIH institutes and other federal government agencies by improving the capability to rapidly conduct peer-reviewed technology research to facilitate aging in place, with a special emphasis on people from underrepresented groups. A platform is a group of technologies that are used as a base upon which other applications, processes or technologies are developed.
|
|
Interagency Working Group on Neuroscience
|
Other
|
CDC, FDA
|
NIMH, NIA, NIDA, NINDS, NINR, OD/DPCPSI/OBSSR
|
By Executive Order, the White House Office of Science and Technology Policy established the Interagency Working Group on Neuroscience (IWGN) by action of the National Science and Technology Council to foster collaboration across agencies and to coordinate federal investments in neuroscience research. The IWGN will coordinate activities in neuroscience research across the Federal Government with a focus on the fundamental understanding of learning, brain development and plasticity, and brain health and recovery. The IWGN will enhance federal efforts related to: improving our understanding of learning and cognition and applying this understanding to improvements in education and other areas; improving our understanding of a variety of neurological conditions and injuries; and developing appropriate resources, tools, techniques, interventions, and therapies to assist in research, treatment, and recovery. The IWGN includes members from the Departments of Agriculture, Defense, Education, Energy, Health and Human Services, Homeland Security, Justice, and Veterans Affairs, as well as the Central Intelligence Agency, Environmental Protection Agency, National Aeronautics and Space Administration, the National Science Foundation, and the Office of the Director of National Intelligence.
|
|
INTERMACS - Interagency Registry for Mechanically Assisted Circulatory Support
|
Resource Development
|
CMS, FDA
|
NHLBI
|
The Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) is a national registry for patients who are receiving mechanical circulatory support device therapy to treat advanced heart failure. This registry was devised as a joint effort of the National Heart, Lung, and Blood Institute (NHLBI), the Centers for Medicare and Medicaid Services (CMS), the U.S. Food and Drug Administration (FDA), clinicians, scientists, and industry representatives, in conjunction with the University of Alabama at Birmingham and the United Network for Organ Sharing.
|
|
International Cancer Control Partnership
|
Other
|
CDC
|
NCI
|
The National Cancer Institute and the Union for International Cancer Control convened global partners including CDC to cooperate in assisting countries to develop and implement quality cancer plans linked to Non-communicable Disease (NCD) control. This International Cancer Control Partnership, ICCP, believes that prioritizing cancer is critical to reaching the “25x25” goal. ICCP partners will assist countries by: creating a searchable database of current cancer control plans from around the globe; performing analysis of gaps and highlighting priority areas for inclusion in plans; training appropriate personnel to develop plans with targets and evaluation strategies; providing planners with relevant existing materials and tools; and offering technical assistance. ICCP partners will use their collective state, country and regional-level planning experience to guide plan development and implementation and will ensure planners utilize effective, evidence-based strategies to help meet the global NCD targets.
|
|
International Conference on Betel Quid and Areca Nut
|
Meeting/ Workshop
|
CDC
|
NCI, NIAID, NIDCR
|
Tobacco and areca nut are used in a variety of forms and with other added ingredients throughout Asia and the Pacific. Common forms of areca nut use include: betel quid, a combination of betel leaf, areca nut, and slaked lime, which may be used with or without tobacco and is typically assembled for the customer; and gutka, a packaged product containing areca nut, slaked lime, and tobacco. Other ingredients and flavorants are often added according to local preferences and customs (e.g., sweeteners; catechu; or spices such as cardamom, saffron, cloves, anise seeds, turmeric, and mustard). While both tobacco and areca nut are known carcinogens, other ingredients may also contribute to the toxic or addictive properties of the product.
Betel quid and areca nut use is common in Asian and Pacific countries. The 2009–2010 Asian Betel–Quid Consortium study found that use of betel quid with tobacco among adults aged 15 and older ranges widely across several countries in the region. For example, prevalence is high in Nepal (males, 43.6%; females, 34.9%) and among women in Indonesia (31.7% among females, compared to 10.4% among males). The CDC Global Adult Tobacco Survey in India (2009–2010) shows that about 6.2% percent of all adults aged 15 years and older (7.5% of males and 4.9% of females) report using betel quid with tobacco. Betel quid, is a risk factor for oral and esophageal cancers, and has shown effects on the cardiovascular, nervous, GI and metabolic, respiratory, and reproductive systems.
The International Agency for Research on Cancer Monograph 85 (2004) examined the carcinogenic effects of betel quid and areca nut chewing and concluded that betel quid, both with and without tobacco, is carcinogenic to humans. However, the relative contribution of specific ingredients to the carcinogenic and addictive properties of betel quid is not well characterized. Additionally, the practice of betel quid use, added ingredients, and cultural role vary widely across the region. Moreover, tobacco control policies and interventions are not necessarily applied to betel quid chewing, even when the product contains tobacco. More research is needed to understand effective prevention and control of betel quid use (alone or in combination with cigarette smoking and/or alcohol), screening and treatment for related cancers, policy and economic impacts, cessation, and basic biology.
This proposed conference will focus on understanding the impact of use of areca nut and betel quid, both with and without tobacco, and all its variants, addiction issues, and the associated cancers and other oral health issues, specifically cancers of the lip, mouth, tongue, pharynx, and esophagus.
|
|
Intradepartmental Council for Native American Affairs (ICNAA)
|
Committee, Work group, Advisory group, or Task Force
|
ACF, ACL, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
NIMHD
|
The purpose of this collaborative activity is to support activities of the Intradepartmental Council for Native American Affairs (ICNAA), including tribal consultation sessions and development of the annual tribal consultation report.
|
|
Intragovernmental Select Agents and Toxins Technical Advisory Committee (ISATTAC)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, OS
|
OD/OSP, NCI, NIAID
|
The Intragovernmental Select Agents and Toxins Technical Advisory Committee (ISATTAC) makes technically based recommendations to the APHIS/CDC Select Agent and Toxin Program on restricted experiments of Select Agents and Toxins and the exclusion and exemption of attenuated strains. The Committee also conducts a biennial review of the Select Agents and Toxins list for HHS and overlap agents and toxins.
|
|
Investigations of Early Life Determinants of Pediatric and Adult Malignancies in a Population
|
Research Initiative
|
CDC
|
NCI
|
In collaboration with investigators from the U.S. Centers for Disease Control and Prevention (CDC) and the China CDC, the National Cancer Institute (NCI) is assessing risk of pediatric leukemia and other pediatric cancers in a large population of offspring of mothers enrolled in a community intervention program of peri-conception folic acid supplementation in China. Pediatric cancer risks will be compared in offspring of mothers treated vs offspring of mothers not treated with folic acid supplements.
|
|
IOM Consensus Study: Public Health Approaches to Reduce Vision Impairment and Promote Eye Health.
|
Meeting/ Workshop
|
CDC
|
NEI
|
The Institute of Medicine will conduct a consensus study to examine the core principles and public health strategies to reduce visual impairment and promote eye health in the United States. The study will describe limitations and opportunities to improve vision and eye health surveillance; reduce vision and eye health disparities; promote evidence-based strategies to improve knowledge, access and utilization to eye care; identify comorbid conditions and characterize their impact; and, promote health for people with vision impairment. The study will also examine the potential for public and private collaborations at the community, state, and national levels to elevate vision and eye health as a public health issue.
|
|
It’s a Noisy Planet. Protect Their Hearing® Public Education campaign
|
Public Education Campaign
|
CDC
|
NIDCD
|
The National Institute on Deafness and Other Communication Disorders (NIDCD) sponsors, It’s a Noisy Planet Protect Their Hearing®, a national public education campaign to increase awareness among parents of children ages 8 to 12 about the causes and prevention of noise-induced hearing loss (NIHL). The campaign disseminates messages through print and digital materials, community-based events, school presentations, and other methods. The campaign launched in October 2008 as a follow up to the NIDCD''''s Wise Ears! campaign, which increased awareness about preventing NIHL among workers, employers, and Americans of all ages from 1999 to 2008. The CDC’s National Institute for Occupational Safety and Health (NIOSH) has actively collaborated with the NIDCD for both campaigns.
|